reconstitution for retatrutide Dosing Guide Researchers Retatrutide Research Peptide | GLP3-R

Retatrutide helps the body reduce calorie intake by lowering appetite and cravings, but it also stimulates fat metabolism through its glucagon activity

It is often used to support fat metabolism, liver function, and antioxidant activity as part of a weight management plan

Interest in GLP-1 medications is higher in the U.S

Someone starting at 280 pounds averages larger total loss than someone starting at 200 pounds, though percentage may be similar

GLP-1s work best when combined with healthy lifestyle habits

Phase 2 trial data (published in New England Journal of Medicine, 2023 ): 24.2% average weight loss at 48 weeks with 12 mg dose 22.8% with 8 mg dose Placebo group lost 2.1% Most recent Phase 3 trial data (TRIUMPH-4, December 2025): 28.7% average weight loss at 68 weeks with 12 mg dose 26.4% with 9 mg dose 58.6% of participants on 12 mg achieved at least 25% weight loss 39.4% achieved at least 30% weight loss For context: These are the highest weight loss numbers reported in any clinical trial for a pharmacological obesity treatment